Transparency Market Research has published a new report, titled “Prenatal Genetic Testing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025.” According to the report one of the primary factors bolstering the demand for prenatal genetic testing is the rising incidences and prevalence of genetic disorders such as Down syndrome, Edward syndrome, and Patau syndrome. Another important factor boosting the demand for prenatal genetic testing is the growing desire to know the sex of the foetus.
The global prenatal genetic testing market is benefiting largely on account of the increasing efforts taken by private and public organizations such as National Human Genome Research Institute, and genomic Health Inc. which are carrying out extensive research and development activities relating to genomics and proteomics. An equally impressive amount of efforts taken by market players have resulted in the development of novel diagnostic technologies, tests, and tools which in turn are responsible for the growth of the global prenatal genetic testing market.
The report not only discusses the various factors fuelling the growth of the global prenatal genetic testing market but also draws the attention of the readers, the words the various factors which opposed the growth of the prenatal genetic testing market. One of the key factors challenging the growth of this market is the high capital requirement. Strict government regulations for prenatal genetic test will also act as a hindrance.
On the basis of geography, the global prenatal genetic testing market is segmented into Europe, asia-pacific, Latin America, North America, and the Middle East and Africa. On account of the presence of advanced technologies such as Multiplex PCR technology, PCR equipment, and others, North America has been leading within the prenatal genetic testing market and is anticipated to continue to do so on account of the favourable government policies that mandates a proper screening of genetic abnormalities and diagnosis of the same. Apart from North America, the lead author of this report states that “the emerging nations in Asia Pacific are anticipated to be lucrative markets for prenatal genetic testing on account of rapid improvement in the healthcare infrastructure and health care service, growing awareness of genetic disease diagnosis, increasing income, and a number of plans and policies by the government.
Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37841
On the basis of test type, the global prenatal genetic testing market is segmented into screen tests and diagnostic tests. By end-user, the global prenatal genetic testing market is segmented into speciality clinics, hospitals, and diagnostic centers. The report not only points out the leading segment or sub-segments but also reveals the declining or the segment anticipated to witness segment anticipated to witness sluggish growth. The fastest growing segment or sub-segments is also divulged in the report.
Leading players operating within the global prenatal genetic testing market are profiled for the purpose of study. This section of the report comprises the business and financial overview of the companies, information about their latest collaborations, Partnerships, mergers, and acquisitions. The strategies employed by the companies in order to stay ahead of market competition as well as the recent developments by the companies are also revealed. The names of the leading players with in the market mentioned in the report are: Myriad Genetics, Inc., Bio-Rad Laboratories Inc., Illumina, Inc., Agilent Technologies Inc., Natera Inc., and PreventionGenetics.